Supplemental material
Expert Review of Vaccines
Volume 23, 2024 - Issue 1
Open access
1,358
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan
Mitsuhiro Naganoa Health and Value, Pfizer Japan Inc., Tokyo, JapanCorrespondence[email protected]
View further author information
, View further author information
Kazumasa Kameia Health and Value, Pfizer Japan Inc., Tokyo, JapanView further author information
, Hiroyuki Matsudab RWES HEOR, IQVIA Solutions Japan G.K., Tokyo, JapanView further author information
, Chihiro Takahashic mRNA & Antiviral Medical Affairs, Pfizer Japan Inc., Tokyo, JapanView further author information
, Jingyan Yangd Global Access and Value, Pfizer Inc., New York, NY, USA;e Institute for Social and Economic Research and Policy, Columbia University, New York, NY, USAView further author information
, Koji Wadac mRNA & Antiviral Medical Affairs, Pfizer Japan Inc., Tokyo, JapanView further author information
& Naohiro Yonemotoa Health and Value, Pfizer Japan Inc., Tokyo, JapanView further author information
show all
Pages 349-361
|
Received 27 Dec 2023, Accepted 21 Feb 2024, Published online: 05 Mar 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.